Lockheed Martin Investment Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-20,000
Closed -$4.25M 156
2014
Q4
$4.25M Sell
20,000
-7,200
-26% -$1.43M 0.18% 41
2014
Q3
$4.85M Buy
27,200
+2,000
+8% +$332K 0.22% 38
2014
Q2
$4.26M Sell
25,200
-61,000
-71% -$9.5M 0.19% 48
2014
Q1
$10.7M Sell
86,200
-68,000
-44% -$8.28M 0.55% 36
2013
Q4
$17.1M Buy
154,200
+62,000
+67% +$5.92M 0.95% 20
2013
Q3
$8.34M Buy
92,200
+17,000
+23% +$1.53M 0.47% 34
2013
Q2
$6.33M Buy
+75,200
New +$7.8M 0.39% 28

Other funds holding AGN

Lockheed Martin Investment Management's AGN Position: Q1 2015 in Review

Lockheed Martin Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 20,000 shares — an estimated $4.25M sold.

Lockheed Martin Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $17.1M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Lockheed Martin Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 20,000 Allergan Inc shares in Q1 2015, an estimated $4.25M.
  • Lockheed Martin Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Lockheed Martin Investment Management's Allergan Inc position peaked at $17.1M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Lockheed Martin Investment Management's 13F filing for Q1 2015, filed 8 May 2015.